Impact of the Coronavirus Disease 2019 (COVID-19) Pandemic on Cervical Cancer Screening in Gynecological Practices in Germany
Niklas Gremke(Philipps University of Marburg), Matthias Kalder(Philipps University of Marburg), Sebastian Griewing(Philipps University of Marburg), Karel Kostev, Markus Felgentreff(Philipps University of Marburg)
Cited by 10
Related Papers
mTOR-mediated cancer drug resistance suppresses autophagy and generates a druggable metabolic vulnerability
|Nature Communications|2020|171
Challenging ChatGPT 3.5 in Senology—An Assessment of Concordance with Breast Cancer Tumor Board Decision Making
|Journal of Personalized Medicine|2023|70
Evolution of publicly available large language models for complex decision-making in breast cancer care
|Archives of Gynecology and Obstetrics|2024|28
Positive association between body height and breast cancer prevalence: a retrospective study with 135,741 women in Germany
|Breast Cancer Research and Treatment|2022|19
Targeting PI3K inhibitor resistance in breast cancer with metabolic drugs
|Signal Transduction and Targeted Therapy|2025|19